Adaptive Biotechnologies
Stock Forecast, Prediction & Price Target
Adaptive Biotechnologies Financial Estimates
Adaptive Biotechnologies Revenue Estimates
Adaptive Biotechnologies EBITDA Estimates
Adaptive Biotechnologies Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $154.34M N/A | $185.30M 20.06% | $170.27M -8.11% | Avg: $206.73M Low: $195.93M High: $216.99M avg. 21.40% | Avg: $267.31M Low: $253.45M High: $279.31M avg. 29.30% | ||
Net Income
% change YoY
| $-205.61M N/A | $-142.46M 30.71% | $-225.25M -58.11% | Avg: $-147.95M Low: $-194.91M High: $-114.78M avg. 34.31% | Avg: $-127.21M Low: $-171.81M High: $-88.29M avg. 14.02% | ||
EBITDA
% change YoY
| $-207.26M N/A | $-194.43M 6.19% | $-189.27M 2.65% | Avg: $-202.65M Low: $-212.72M High: $-192.07M avg. -7.07% | Avg: $-262.04M Low: $-273.81M High: $-248.46M avg. -29.30% | ||
EPS
% change YoY
| -$1.46 N/A | -$1 31.50% | -$1.56 -56.00% | Avg: -$1.05 Low: -$1.35 High: -$0.79 avg. 32.63% | Avg: -$0.84 Low: -$1.19 High: -$0.61 avg. 19.78% | ||
Operating Expenses
% change YoY
| $314.00M N/A | $327.58M 4.32% | $321.75M -1.77% | Avg: $208.53M Low: $197.64M High: $218.89M avg. -35.18% | Avg: $269.64M Low: $255.67M High: $281.76M avg. 29.30% | ||
FAQ
What is Adaptive Biotechnologies stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 24.16% in 2025-2026.
We have gathered data from 6 analysts. Their low estimate is -194.91M, average is -147.95M and high is -114.78M.
What is Adaptive Biotechnologies stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 25.35% in 2025-2026.
We have gathered data from 7 analysts. Their low revenue estimate is $195.93M, average is $206.73M and high is $216.99M.
What is Adaptive Biotechnologies stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 26.21% in 2025-2026.
We have gathered data from 6 analysts. Their low earnings per share estimate is -$1.35, average is -$1.05 and high is $-0.79.
What is the best performing analyst?
In the last twelve months analysts have been covering Adaptive Biotechnologies stock. The most successful analyst is Mark Massaro.